Duncan Porter’s Post

🔎 Today let's focus on ovarian cancer with this insightful article from the Mayo Clinic Comprehensive Cancer Center Blog, exploring the latest treatments and groundbreaking research! 👇 https://hubs.li/Q02G0dK80 #ClinicalTrial #MayoClinic #OvarianCancer

➡️ This morning, a post that looks at some findings in #lungcancer, which in most countries, claims more lives each year than breast, colon, and prostate cancer combined. 🙏 Not the most uplifting topic but important research to hopefully, drive better treatements and #patient outcomes in the coming years and decades. 🤔 We should also be mindful not to stigmatize people with lung cancer as it has several causes. #cancer #stigma #sciencematters #researchmatters

Castle Biosciences' TissueCypher® test can offer patients with Barrett's esophagus a clearer picture of their risk of developing esophageal cancer, which is the 8th most common form of cancer worldwide and the 6th leading cause of cancer death (due in part to late diagnoses). Learn more about how TissueCypher can help (via USA TODAY and Mediaplanet USA): https://lnkd.in/gMBycc73

Castle Biosciences' TissueCypher® test can offer patients with Barrett's esophagus a clearer picture of their risk of developing esophageal cancer, which is the 8th most common form of cancer worldwide and the 6th leading cause of cancer death (due in part to late diagnoses). Learn more about how TissueCypher can help (via USA TODAY and Mediaplanet USA): https://lnkd.in/gMBycc73

According to early clinical data, a new experimental blood test can detect stage 1 and 2 pancreatic cancer with 97% accuracy. Although pancreatic cancer accounts for just 3% of new cancer diagnoses, it's one of the most fatal due to the difficulty of detecting it at an early stage. A quicker and earlier diagnosis means it's much more likely the cancer can be surgically removed before it spreads to other parts of the body, significantly increasing the likelihood of a full recovery. The clinical trial included patients from the US and Asia and will now be studied on a larger scale. #liquidbiopsy #IVD #cancerdiagnostics

What is driving my cancer? - Matthew Ellis https://lnkd.in/gRdeBgEx #oncodaily #oncology #cancer #cancerresearch #cancerdiagnosis #precisionmedicine #cancerdrivers #moleculardiagnostics #proteogenomics #proteomicanalysis #biomarkers #treatmentdevelopment #pathology #clinicaltrials

Breast Cancer Blood Test Hailed As A Breakthrough! A new type of “ultra-sensitive” blood test can predict if breast cancer will return in high-risk patients long before they relapse and symptoms show up on scans, according to scientists at the Institute of Cancer Research (ICR) in London, England... https://bit.ly/3T9NteQ #cancer #breastcancer #bloodcancer #cancersucks #health #cancersurvivor #c #cancerawareness #cancerfighter #oncology #oncologia #chemotherapy #cancerwarrior #cancersupport #cancerresearch #chemo #cancertreatment

As CNN reports, researchers are looking to blood-based biomarkers as an innovative early detection tool for pancreatic cancer. Dr. Brian Wolpin, director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, explains that the lack of screening tests means too many patients are being diagnosed in the later, more lethal stages of this disease. “The more patients we can find early, the greater the chance we have to cure patients of pancreatic cancer and start to reverse the statistics.” These sentiments are exactly why we are proudly investing in MD Anderson Cancer Center's study that is harnessing AI to integrate imaging and blood-based biomarkers. Learn more: https://lnkd.in/gyp_36Cb #pancreaticcancer #cancerresearch #cancerscreening #earlydetection

March is #ColorectalCancerAwarenessMonth! Each year, nearly 1.9 million people are diagnosed with colorectal cancer, accounting for nearly 10% of all cancer incidents across the globe. It is the third most common cancer globally and also the second leading cause of cancer-related deaths. Regular screening and knowing what the risk factors are is incredibly important for reducing your risk of being diagnosed, as well as improving your prognosis after diagnosis. For more information on colorectal cancer and its risk factors, visit: https://lnkd.in/gcpa9G4J

Today the CDMRP released a nice writeup of our DOD-funded work in liquid biopsy using methylation markers to monitor disease load in patients with metastatic breast cancer and to prognosticate outcome. I hope you enjoy reading it. Here is the link: https://lnkd.in/e6uSN8Se